Literature DB >> 29341965

Osmotic Shifts, Cerebral Edema, and Neurologic Deterioration in Severe Hepatic Encephalopathy.

Eric Michael Liotta1,2, Anna L Romanova3, Bryan D Lizza4, Laura J Rasmussen-Torvik5, Minjee Kim1, Brandon Francis6, Rajbeer Singh Sangha1, Timothy J Carroll7, Daniel Ganger8, Daniela P Ladner2, Andrew M Naidech1, James J Paparello9, Shyam Prabhakaran1, Farzaneh A Sorond1, Matthew B Maas1.   

Abstract

OBJECTIVES: We sought to determine the effect of acute electrolyte and osmolar shifts on brain volume and neurologic function in patients with liver failure and severe hepatic encephalopathy.
DESIGN: Retrospective analysis of brain CT scans and clinical data.
SETTING: Tertiary care hospital ICUs. PATIENTS: Patients with acute or acute-on-chronic liver failure and severe hepatic encephalopathy.
INTERVENTIONS: Clinically indicated CT scans and serum laboratory studies.
MEASUREMENTS AND MAIN RESULTS: Change in intracranial cerebrospinal fluid volume between sequential CT scans was measured as a biomarker of acute brain volume change. Corresponding changes in serum osmolality, chemistry measurements, and Glasgow Coma Scale were determined. Associations with cerebrospinal fluid volume change and Glasgow Coma Scale change for initial volume change assessments were identified by Spearman's correlations (rs) and regression models. Consistency of associations with repeated assessments was evaluated using generalized estimating equations. Forty patients were included. Median baseline osmolality was elevated (310 mOsm/Kg [296-321 mOsm/Kg]) whereas sodium was normal (137 mEq/L [134-142 mEq/L]). Median initial osmolality change was 9 mOsm/kg (5-17 mOsm/kg). Neuroimaging consistent with increased brain volume occurred in 27 initial assessments (68%). Cerebrospinal fluid volume change was more strongly correlated with osmolality (r = 0.70; p = 4 × 10) than sodium (r = 0.28; p = 0.08) change. Osmolality change was independently associated with Glasgow Coma Scale change (p = 1 × 10) and cerebrospinal fluid volume change (p = 2.7 × 10) in initial assessments and in generalized estimating equations using all 103 available assessments.
CONCLUSIONS: Acute decline in osmolality was associated with brain swelling and neurologic deterioration in severe hepatic encephalopathy. Minimizing osmolality decline may avoid neurologic deterioration.

Entities:  

Mesh:

Year:  2018        PMID: 29341965      PMCID: PMC5774236          DOI: 10.1097/CCM.0000000000002831

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  40 in total

1.  Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF).

Authors:  Juan Cordoba; Meritxell Ventura-Cots; Macarena Simón-Talero; Àlex Amorós; Marco Pavesi; Hendrik Vilstrup; Paolo Angeli; Marco Domenicali; Pere Ginés; Mauro Bernardi; Vicente Arroyo
Journal:  J Hepatol       Date:  2013-10-12       Impact factor: 25.083

Review 2.  Hyperosmolar therapy for raised intracranial pressure.

Authors:  Allan H Ropper
Journal:  N Engl J Med       Date:  2012-08-23       Impact factor: 91.245

3.  Dialysis disequilibrium syndrome (DDS) in the rat: role of the "reverse urea effect".

Authors:  S M Silver; J A DeSimone; D A Smith; R H Sterns
Journal:  Kidney Int       Date:  1992-07       Impact factor: 10.612

Review 4.  Review article: the design of clinical trials in hepatic encephalopathy--an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement.

Authors:  J S Bajaj; J Cordoba; K D Mullen; P Amodio; D L Shawcross; R F Butterworth; M Y Morgan
Journal:  Aliment Pharmacol Ther       Date:  2011-02-09       Impact factor: 8.171

5.  Molecular basis for the dialysis disequilibrium syndrome: altered aquaporin and urea transporter expression in the brain.

Authors:  Marie-Marcelle Trinh-Trang-Tan; Jean-Pierre Cartron; Lise Bankir
Journal:  Nephrol Dial Transplant       Date:  2005-06-28       Impact factor: 5.992

Review 6.  Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management.

Authors:  Pere Ginès; Mónica Guevara
Journal:  Hepatology       Date:  2008-09       Impact factor: 17.425

Review 7.  Liver-brain proinflammatory signalling in acute liver failure: role in the pathogenesis of hepatic encephalopathy and brain edema.

Authors:  Chantal Bémeur; Roger F Butterworth
Journal:  Metab Brain Dis       Date:  2012-12-05       Impact factor: 3.584

8.  Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis.

Authors:  Mónica Guevara; M E Baccaro; Aldo Torre; Beatriz Gómez-Ansón; José Ríos; Ferrán Torres; Lorena Rami; Gemma C Monté-Rubio; Marta Martín-Llahí; Vicente Arroyo; Pere Ginès
Journal:  Am J Gastroenterol       Date:  2009-06       Impact factor: 10.864

9.  Acute Physiology and Chronic Health Evaluation (APACHE) IV: hospital mortality assessment for today's critically ill patients.

Authors:  Jack E Zimmerman; Andrew A Kramer; Douglas S McNair; Fern M Malila
Journal:  Crit Care Med       Date:  2006-05       Impact factor: 7.598

10.  Surveillance neuroimaging and neurologic examinations affect care for intracerebral hemorrhage.

Authors:  Matthew B Maas; Neil F Rosenberg; Adam R Kosteva; Rebecca M Bauer; James C Guth; Eric M Liotta; Shyam Prabhakaran; Andrew M Naidech
Journal:  Neurology       Date:  2013-06-05       Impact factor: 9.910

View more
  7 in total

1.  Serum osmolality, cerebrospinal fluid specific gravity and overt hepatic encephalopathy severity in patients with liver failure.

Authors:  Eric M Liotta; Constantine J Karvellas; Minjee Kim; Ayush Batra; Andrew Naidech; Shyam Prabhakaran; Farzaneh A Sorond; W Taylor Kimberly; Matthew B Maas
Journal:  Liver Int       Date:  2020-02-12       Impact factor: 5.828

Review 2.  Cerebral edema and liver disease: Classic perspectives and contemporary hypotheses on mechanism.

Authors:  Eric M Liotta; W Taylor Kimberly
Journal:  Neurosci Lett       Date:  2020-02-05       Impact factor: 3.046

3.  The authors reply.

Authors:  Eric Michael Liotta; Daniel Ganger; Daniela P Ladner; Matthew B Maas
Journal:  Crit Care Med       Date:  2018-07       Impact factor: 7.598

Review 4.  Hyponatremia in the Neurologically Ill Patient: A Review.

Authors:  David P Lerner; Starane A Shepherd; Ayush Batra
Journal:  Neurohospitalist       Date:  2020-01-10

5.  Cerebral Herniation from Hyperammonemic Cerebral Edema: A Potentially Reversible Neurological Emergency.

Authors:  Andrea Loggini; Raisa C Martinez; Christopher L Kramer
Journal:  Neurocrit Care       Date:  2019-06       Impact factor: 3.210

6.  TRPV4 channels mediate the mechanoresponse in retinal microglia.

Authors:  Sarah N Redmon; Oleg Yarishkin; Monika Lakk; Andrew Jo; Edin Mustafić; Petr Tvrdik; David Križaj
Journal:  Glia       Date:  2021-02-24       Impact factor: 8.073

Review 7.  Acute pediatric hyperammonemia: current diagnosis and management strategies.

Authors:  Nadia Savy; David Brossier; Catherine Brunel-Guitton; Laurence Ducharme-Crevier; Geneviève Du Pont-Thibodeau; Philippe Jouvet
Journal:  Hepat Med       Date:  2018-09-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.